meciadanol has been researched along with aspirin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brzozowski, T; Kitler, ME; Konturek, SJ; Radecki, T | 1 |
| Kitler, ME; Konturek, SJ; Kopp, B; Kwiecien, N; Obtulowicz, W; Oleksy, J | 1 |
| Hennings, G; Parmar, NS | 1 |
| Ganote, DP; Hennings, G; Lücker, PW | 1 |
4 other study(ies) available for meciadanol and aspirin
| Article | Year |
|---|---|
Gastric protection by meciadanol. A new synthetic flavonoid inhibiting histidine decarboxylase.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Anti-Ulcer Agents; Aspirin; Benzopyrans; Carboxy-Lyases; Catechin; Epoprostenol; Ethanol; Female; Gastric Acid; Gastric Mucosa; Histidine Decarboxylase; Male; Rats; Rats, Inbred Strains; Stomach Ulcer; Time Factors | 1986 |
Effect of meciadanol on gastric secretion and aspirin-induced gastric mucosal injury in humans.
Topics: Adult; Aspirin; Benzopyrans; Catechin; DNA; Dose-Response Relationship, Drug; Gastric Acid; Gastric Mucosa; Histamine; Humans; Pepsin A | 1984 |
The effect of 3-methoxy-5,7,3',4'-tetrahydroxyflavan on the restraint induced gastric ulceration augmented by aspirin, a gastric mucosal barrier breaker.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Catechin; Cimetidine; Flavonoids; Gastric Mucosa; Male; Rats; Restraint, Physical; Stomach Ulcer | 1983 |
3-Methoxy-5,7,3',4'-tetrahydroxyflavan (ME): a new compound to prevent gastric irritation. A gastric potential difference analysis.
Topics: Aspirin; Catechin; Dose-Response Relationship, Drug; Flavonoids; Gastric Mucosa; Humans; Irritants; Male; Membrane Potentials; Random Allocation; Stomach Diseases | 1983 |